Literature DB >> 21638942

Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21638942

Source DB:  PubMed          Journal:  Technol Eval Cent Assess Program Exec Summ


× No keyword cloud information.
  1 in total

1.  Use of epidermal growth factor receptor mutation analysis in patients with advanced non-small-cell lung cancer to determine erlotinib use as first-line therapy.

Authors:  Naoko Ishibe; Josh Carlson; Scott David Ramsey; Andrew Freedman; Sheri Schully
Journal:  PLoS Curr       Date:  2011-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.